Physician profile
Steven Lerner
NPI 1811091440
$6,399.22
in general payments reported to CMS, 2019-2025
19 companies · $1,223 in 2025
The $1,223 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $141 · 2021: $824 · 2022: $939 · 2023: $1,165 · 2024: $1,444 · 2025: $1,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,832.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,031.06 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,716.63 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $895.36 | 2019-2024 | |
| Abbvie INC. | $351.34 | 2021-2024 | |
| Amgen INC. | $291.34 | 2021-2025 | Tezspire, Repatha, Otezla |
| Insmed, INC. | $168.66 | 2021-2025 | Arikayce |
| Mallinckrodt Hospital Products INC. | $128.84 | 2024 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $122.23 | 2019 | |
| United Therapeutics Corporation | $110.45 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $103.97 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $84.60 | 2021-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Lilly USA, LLC | $81.24 | 2021-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $71.28 | 2024-2025 | |
| Inspire Medical Systems, INC. | $62.50 | 2024 | Inspire |
| Mallinckrodt Enterprises LLC | $59.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $45.64 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $36.42 | 2024 | Opsumit |
| Exact Sciences Corporation | $22.28 | 2024 | Cologuard Collection Kit |
| Philips North America LLC | $16.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.